PCSA logo

Processa Pharmaceuticals (PCSA) Enterprise Value

Enterprise Value

$700.98 K
+$16.33 K+2.39%

Tue, 03 Dec 2024 14:30:00 GMT

PCSA Enterprise Value Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PCSA Enterprise Value Performance

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
todaytoday+2.4%+0.5%+0.5%
1 m1 month--7.0%-7.0%
3 m3 months+170.8%-21.7%-21.9%
6 m6 months+116.2%-21.6%-31.4%
ytdytd-82.7%-59.4%-84.0%
1 y1 year-94.2%-81.3%-93.0%
5 y5 years-98.8%-93.9%-99.5%

PCSA Enterprise Value High & Low

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1 month$799 K-12.3%$48 K+1362.5%
3 m3 months$799 K-12.3%-$1 M+154.6%
6 m6 months$1.45 M-51.7%-$4 M+116.2%
1 y1 year$14 M-95.0%-$5 M+115.5%
3 y3 years$65 M-98.9%-$5 M+115.5%
5 y5 years$189 M-99.6%-$5 M+115.5%
alltimeall time$189 M-99.6%-$5 M+115.5%

Processa Pharmaceuticals Enterprise Value History

DateValue
2024
$700.98 K(-82.7%)
2023
$4.06 M(-64.3%)
2022
$11.37 M(-81.2%)
2021
$60.56 M(-22.8%)
2020
$78.48 M(-20.8%)
DateValue
2019
$99.08 M(-28.0%)
2018
$137.69 M(-11.0%)
2017
$154.77 M(+3455.4%)
2016
$4.35 M(-24.4%)
2015
$5.75 M(-76.7%)
2014
$24.72 M

FAQ

  • What is Processa Pharmaceuticals enterprise value?
  • What is the all time high enterprise value for Processa Pharmaceuticals?
  • What is PCSA enterprise value year-to-date change?
  • What is Processa Pharmaceuticals enterprise value year-on-year change?

What is Processa Pharmaceuticals enterprise value?

The current enterprise value of PCSA is $700.98 K

What is the all time high enterprise value for Processa Pharmaceuticals?

Processa Pharmaceuticals all-time high enterprise value is $188.87 M

What is PCSA enterprise value year-to-date change?

Processa Pharmaceuticals enterprise value has changed by -$3.36 M (-82.74%) since the beginning of the year

What is Processa Pharmaceuticals enterprise value year-on-year change?

Over the past year, PCSA enterprise value has changed by -$11.33 M (-94.17%)